• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢向谷氨酰胺的转变调节卵巢癌的肿瘤生长、侵袭和生物能量学。

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.

机构信息

Laboratory for Systems Biology of Human Diseases, Rice University, Houston, TX, USA.

出版信息

Mol Syst Biol. 2014 May 5;10(5):728. doi: 10.1002/msb.20134892.

DOI:10.1002/msb.20134892
PMID:24799285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4188042/
Abstract

Glutamine can play a critical role in cellular growth in multiple cancers. Glutamine-addicted cancer cells are dependent on glutamine for viability, and their metabolism is reprogrammed for glutamine utilization through the tricarboxylic acid (TCA) cycle. Here, we have uncovered a missing link between cancer invasiveness and glutamine dependence. Using isotope tracer and bioenergetic analysis, we found that low-invasive ovarian cancer (OVCA) cells are glutamine independent, whereas high-invasive OVCA cells are markedly glutamine dependent. Consistent with our findings, OVCA patients' microarray data suggest that glutaminolysis correlates with poor survival. Notably, the ratio of gene expression associated with glutamine anabolism versus catabolism has emerged as a novel biomarker for patient prognosis. Significantly, we found that glutamine regulates the activation of STAT3, a mediator of signaling pathways which regulates cancer hallmarks in invasive OVCA cells. Our findings suggest that a combined approach of targeting high-invasive OVCA cells by blocking glutamine's entry into the TCA cycle, along with targeting low-invasive OVCA cells by inhibiting glutamine synthesis and STAT3 may lead to potential therapeutic approaches for treating OVCAs.

摘要

谷氨酰胺在多种癌症的细胞生长中起着关键作用。依赖谷氨酰胺的癌细胞依赖谷氨酰胺才能存活,它们的代谢通过三羧酸(TCA)循环被重新编程以利用谷氨酰胺。在这里,我们发现了癌症侵袭性和谷氨酰胺依赖性之间缺失的一环。我们使用同位素示踪和生物能量分析发现,低侵袭性卵巢癌(OVCA)细胞不依赖谷氨酰胺,而高侵袭性 OVCA 细胞则明显依赖谷氨酰胺。与我们的发现一致,OVCA 患者的微阵列数据表明,谷氨酰胺分解与预后不良相关。值得注意的是,谷氨酰胺合成与分解相关基因表达的比值已成为患者预后的新型生物标志物。重要的是,我们发现谷氨酰胺调节 STAT3 的激活,STAT3 是信号通路的介导物,可调节高侵袭性 OVCA 细胞中的癌症特征。我们的研究结果表明,通过阻断谷氨酰胺进入 TCA 循环来靶向高侵袭性 OVCA 细胞,以及通过抑制谷氨酰胺合成和 STAT3 来靶向低侵袭性 OVCA 细胞的联合方法可能为治疗 OVCAs 提供潜在的治疗方法。

相似文献

1
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.代谢向谷氨酰胺的转变调节卵巢癌的肿瘤生长、侵袭和生物能量学。
Mol Syst Biol. 2014 May 5;10(5):728. doi: 10.1002/msb.20134892.
2
Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.白细胞介素-6 信号转导调节人卵巢癌细胞的锚定非依赖性生长、增殖、黏附和侵袭。
Cytokine. 2012 Aug;59(2):228-36. doi: 10.1016/j.cyto.2012.04.020. Epub 2012 May 15.
3
Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells.一氧化氮是卵巢癌细胞中瓦伯格效应的正向调节因子。
Cell Death Dis. 2014 Jun 26;5(6):e1302. doi: 10.1038/cddis.2014.264.
4
Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion.卵巢癌细胞分泌的白细胞介素-8 可增加非锚定依赖性生长、增殖、血管生成潜能、黏附和侵袭。
Cytokine. 2012 Jul;59(1):145-55. doi: 10.1016/j.cyto.2012.04.013. Epub 2012 May 9.
5
miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.miR-450a 通过调节能量代谢在卵巢癌中发挥肿瘤抑制作用。
Cancer Res. 2019 Jul 1;79(13):3294-3305. doi: 10.1158/0008-5472.CAN-19-0490. Epub 2019 May 17.
6
MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.miR-150-5p 通过抑制 c-Myb 介导的 Slug 抑制作用促进细胞迁移,是复发性卵巢癌的预后生物标志物。
Oncogene. 2020 Jan;39(4):862-876. doi: 10.1038/s41388-019-1025-x. Epub 2019 Sep 30.
7
DAAM1-mediated migration and invasion of ovarian cancer cells are suppressed by miR-208a-5p.DAAM1 介导的卵巢癌细胞迁移和侵袭受 miR-208a-5p 的抑制。
Pathol Res Pract. 2019 Jul;215(7):152452. doi: 10.1016/j.prp.2019.152452. Epub 2019 May 14.
8
miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.miRNA-301b-3p 通过靶向 CPEB3/EGFR 轴促进高级别卵巢浆液性肿瘤的迁移和侵袭。
J Cell Biochem. 2019 Aug;120(8):12618-12627. doi: 10.1002/jcb.28528. Epub 2019 Mar 4.
9
Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.驱动蛋白家族成员 14:卵巢癌的独立预后标志物和潜在治疗靶点。
Int J Cancer. 2012 Apr 15;130(8):1844-54. doi: 10.1002/ijc.26189. Epub 2011 Aug 5.
10
Inhibition of succinate dehydrogenase sensitizes cyclin E-driven ovarian cancer to CDK inhibition.琥珀酸脱氢酶抑制使细胞周期蛋白 E 驱动的卵巢癌细胞对 CDK 抑制敏感。
Biofactors. 2016 Mar-Apr;42(2):171-8. doi: 10.1002/biof.1257. Epub 2016 Jan 30.

引用本文的文献

1
Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential.天然代谢产物作为传感和信号传导机制的调节剂:挖掘抗卵巢癌潜力
Biomedicines. 2025 Jul 26;13(8):1830. doi: 10.3390/biomedicines13081830.
2
GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells.GPT2介导铂耐药卵巢癌细胞中谷氨酰胺代谢驱动的代谢改变。
Sci Rep. 2025 Aug 20;15(1):30528. doi: 10.1038/s41598-025-15707-0.
3
Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior.

本文引用的文献

1
The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation.MEK-ERK 通路对于线粒体 STAT3 的丝氨酸磷酸化和 Ras 介导的转化是必需的。
PLoS One. 2013 Nov 29;8(11):e83395. doi: 10.1371/journal.pone.0083395. eCollection 2013.
2
Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma.血小板衍生生长因子受体α(PDGFRα)在卵巢癌中的靶向治疗及相关生物标志物。
Gynecol Oncol. 2014 Jan;132(1):166-75. doi: 10.1016/j.ygyno.2013.10.027. Epub 2013 Oct 29.
3
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells.
解开线粒体功能密码:揭示卵巢癌发病机制及抑制恶性行为的创新靶点。
J Transl Med. 2025 Jul 24;23(1):819. doi: 10.1186/s12967-025-06840-5.
4
TIMM8B promotes oxidative phosphorylation and glycolysis by inhibiting the mtROS/ASK1/JNK signaling pathway in ovarian cancer.TIMM8B通过抑制卵巢癌中的线粒体活性氧/凋亡信号调节激酶1/应激活化蛋白激酶信号通路来促进氧化磷酸化和糖酵解。
Biol Direct. 2025 Jul 1;20(1):75. doi: 10.1186/s13062-025-00663-6.
5
The Identification of a Key Regulator of Mitochondrial Metabolism, the LRPPRC Protein, as a Novel Therapeutic Target in SDHA-Overexpressing Ovarian Tumors.线粒体代谢关键调节因子LRPPRC蛋白被鉴定为SDHA过表达卵巢肿瘤的新型治疗靶点。
Cancers (Basel). 2025 Jun 11;17(12):1942. doi: 10.3390/cancers17121942.
6
GPT2 mediates metabolic alterations in platinum-resistant ovarian cancer cells.GPT2介导铂耐药卵巢癌细胞的代谢改变。
Res Sq. 2025 May 9:rs.3.rs-6480518. doi: 10.21203/rs.3.rs-6480518/v1.
7
FAO-fueled OXPHOS and NRF2-mediated stress resilience in MICs drive lymph node metastasis.粮农组织驱动的氧化磷酸化和NRF2介导的微小浸润癌应激恢复力促进淋巴结转移。
Proc Natl Acad Sci U S A. 2025 Apr 15;122(15):e2411241122. doi: 10.1073/pnas.2411241122. Epub 2025 Apr 11.
8
[Integrative transcriptomics-metabolomics approach to identify metabolic pathways regulated by glutamine synthetase activity].[采用整合转录组学-代谢组学方法鉴定由谷氨酰胺合成酶活性调控的代谢途径]
Se Pu. 2025 Mar;43(3):207-219. doi: 10.3724/SP.J.1123.2024.04003.
9
Metabolic Objectives and Trade-Offs: Inference and Applications.代谢目标与权衡:推断与应用
Metabolites. 2025 Feb 6;15(2):101. doi: 10.3390/metabo15020101.
10
Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis.微小肽hSPAR通过TRIM21-P27KIP1-mTOR轴调节谷氨酰胺水平并抑制乳腺肿瘤生长。
EMBO J. 2025 Mar;44(5):1414-1441. doi: 10.1038/s44318-024-00359-z. Epub 2025 Jan 28.
丝氨酸、叶酸和甘氨酸代谢对癌细胞 ATP、NADPH 和嘌呤需求的贡献。
Cell Death Dis. 2013 Oct 24;4(10):e877. doi: 10.1038/cddis.2013.393.
4
The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.mTORC1 通路通过抑制 SIRT4 来刺激谷氨酰胺代谢和细胞增殖。
Cell. 2013 May 9;153(4):840-54. doi: 10.1016/j.cell.2013.04.023.
5
A physical sciences network characterization of non-tumorigenic and metastatic cells.非致瘤和转移细胞的物理科学网络特征。
Sci Rep. 2013;3:1449. doi: 10.1038/srep01449.
6
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle.自治疗纳米颗粒抑制肿瘤生长和转移。
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6700-5. doi: 10.1073/pnas.1214547110. Epub 2013 Apr 8.
7
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.谷氨酰胺通过 KRAS 调节的代谢途径支持胰腺癌生长。
Nature. 2013 Apr 4;496(7443):101-5. doi: 10.1038/nature12040. Epub 2013 Mar 27.
8
Staging recurrent ovarian cancer with (18)FDG PET/CT.利用(18)氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(FDG PET/CT)对复发性卵巢癌进行分期
Oncol Lett. 2013 Feb;5(2):593-597. doi: 10.3892/ol.2012.1075. Epub 2012 Dec 13.
9
Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.过量的葡萄糖可诱导胰腺癌细胞缺氧诱导因子-1α的表达,并刺激葡萄糖代谢和细胞迁移。
Cancer Biol Ther. 2013 May;14(5):428-35. doi: 10.4161/cbt.23786. Epub 2013 Feb 1.
10
Src activation by β-adrenoreceptors is a key switch for tumour metastasis.β-肾上腺素受体激活Src 是肿瘤转移的关键开关。
Nat Commun. 2013;4:1403. doi: 10.1038/ncomms2413.